MAKINDO MEDICINEClinical textbook for medical students and doctors
For education and revision only. Not for individual patient decisions or prescribing. Verify current NICE/BNF, MHRA safety advice and local clinical protocols before clinical use. Clinical safety and terms.
Chapter 290
MAKINDO MEDICINE · Biochemistry290

Clinical biochemistry: interpretation, test limitations and case mechanisms

Core principles: mechanisms are emphasised to explain clinical phenomena, physiological measurements and biochemical disease.

Patterns of common biochemical tests

Test patternMechanismImportant caution
High ALT/ASTHepatocellular injury; AST also muscleALT/AST magnitude not direct measure of liver synthetic function
High ALP/GGTCholestasis or hepatobiliary enzyme inductionALP also bone/placenta; GGT supports hepatic source
High bilirubinHaemolysis, hepatocellular dysfunction or obstructionFractionate conjugated vs unconjugated
Raised troponinMyocardial injuryNot synonymous with type 1 MI; need ischaemic evidence and serial change
High CKSkeletal muscle injuryRhabdomyolysis risk depends also on kidney injury/electrolytes
Low albuminInflammation, dilution, low synthesis or lossPoor stand-alone nutritional marker
High lactateIncreased production or reduced clearanceCan occur without tissue hypoxia
Low sodiumExcess water relative to effective soluteExclude artefact and hyperglycaemia-associated shifts
High potassiumReduced excretion, redistribution or cell lysisRule out haemolysed sample, assess urgently if confirmed

Interpreting calcium and bone biochemistry

  • Total calcium is partly albumin bound; albumin-adjusted formulae are imperfect in critical illness and acid–base disturbance, so ionised calcium may be necessary.
  • Primary hyperparathyroidism often shows high calcium, inappropriately normal/high PTH, low-to-normal phosphate; malignancy-associated hypercalcaemia often suppresses PTH.
  • Renal failure can reduce calcitriol and increase phosphate, driving secondary hyperparathyroidism; chronic kidney disease mineral bone disorder is multifactorial.
  • Raised ALP with normal GGT may arise from bone turnover; inspect age, pregnancy, recent fracture and disease context.

Diabetes-related biochemistry and endocrinology

  • HbA1c represents haemoglobin glycation over erythrocyte lifespan; haemolysis, transfusion, haemoglobin variants, pregnancy or altered erythrocyte survival can make it misleading.
  • DKA is driven by insulin deficiency with lipolysis and hepatic ketogenesis; serum beta-hydroxybutyrate is particularly informative and urine acetoacetate may lag recovery.
  • Hyperosmolar hyperglycaemic state involves marked osmotic diuresis and dehydration with variable ketosis; evaluate effective osmolality and sodium correction.
  • Hypoglycaemia work-up can require paired glucose, insulin, C-peptide, proinsulin and sulfonylurea screen when appropriate and supervised.

Biochemical diagnostic reasoning

  • Start with pre-analytical effects: sample haemolysis, tourniquet duration, timing, recent meals, IV infusion contamination, circadian rhythm and medications.
  • Recognise physiological adaptation versus pathology: e.g., pregnancy changes ALP, volume status changes urea, strenuous exercise raises CK/AST.
  • Use trend and context rather than isolated numbers: sensitivity/specificity and reference interval depend on population and assay; a normal result never automatically excludes all disease.
  • For patient care consult current UK laboratory reference ranges, local protocols and up-to-date clinical guidance; this atlas is educational.

Advanced interpretation of biochemical investigations

  • Pre-analytical error: Haemolysis raises measured potassium and releases intracellular enzymes; delayed sample processing changes glucose and lactate; prolonged tourniquet use and posture may affect proteins and calcium. Repeat a suspect sample in clinical context rather than treating an isolated artefact.
  • Reference intervals: A result within a population reference range can be pathological for a person with a large change from baseline. Interpret with prior values, assay variation, biological variability and decision thresholds rather than simply a red/black flag.
  • Calculated calcium: Albumin-adjusted calcium equations may be inaccurate in critically ill patients or abnormal protein states; ionised calcium is preferred when accurate physiological calcium status matters. Magnesium and phosphate profoundly alter calcium/PTH interpretation.
  • Liver biochemistry: Transaminases chiefly reflect hepatocyte injury, ALP/GGT a cholestatic pattern and INR/albumin synthetic function with important limitations. Isolated bilirubin requires fractionation and evaluation of haemolysis and hepatic transport.

Worked biochemical syndromes

  • High anion gap acidosis: Compare anion gap, lactate, ketones, renal function and toxidrome; diabetic ketoacidosis can occur at near-normal glucose during SGLT2 inhibitor therapy.
  • Hypokalaemia: Differentiate GI loss, renal loss and intracellular redistribution using history, magnesium, acid–base and carefully interpreted urine electrolytes. ECG instability and weakness determine urgency.
  • Unexpected endocrine values: Check assay interference, biotin supplementation, binding protein abnormalities and non-thyroidal illness before attributing discordant thyroid tests to rare disease. Dynamic tests and specialist laboratories can resolve complex cases.

Further reading: OpenStax Anatomy & Physiology; USMLE Step 1 framework. Apply current specialist guidance for patient-care decisions. Educational expansion pending clinical editorial sign-off (2026).

End of chapter